Cargando…

Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan

Detalles Bibliográficos
Autor principal: Johnson, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438188/
https://www.ncbi.nlm.nih.gov/pubmed/21434697
http://dx.doi.org/10.18553/jmcp.2011.17.3.200
_version_ 1785092733848780800
author Johnson, Jill
author_facet Johnson, Jill
author_sort Johnson, Jill
collection PubMed
description
format Online
Article
Text
id pubmed-10438188
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104381882023-08-21 Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan Johnson, Jill J Manag Care Pharm Research Academy of Managed Care Pharmacy 2011-04 /pmc/articles/PMC10438188/ /pubmed/21434697 http://dx.doi.org/10.18553/jmcp.2011.17.3.200 Text en Copyright © 2011, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research
Johnson, Jill
Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
title Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
title_full Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
title_fullStr Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
title_full_unstemmed Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
title_short Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
title_sort five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438188/
https://www.ncbi.nlm.nih.gov/pubmed/21434697
http://dx.doi.org/10.18553/jmcp.2011.17.3.200
work_keys_str_mv AT johnsonjill fiveyearexaminationofutilizationanddrugcostoutcomesassociatedwithbenefitdesignchangesincludingreferencepricingforprotonpumpinhibitorsinastateemployeehealthplan